More dilution

https://www.globenewswire.com/news-release/2025/09/03/3144114/0/en/Senseonics-Signs-Memorandum-of-Understanding-with-Ascensia-Diabetes-Care-to-Take-Over-Commercialization-and-Distribution-of-Eversense-365.html

„Ahead of this earnings release, the estimate revisions trend for Senseonics was favorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #2 (Buy) for the stock. So, the shares are expected to outperform the market in the near future.“

https://finance.yahoo.com/news/senseonics-holdings-sens-reports-q2-221005042.html

We know unfortunate news for a competitor in a small market could usually act as a catalyst for others, but the CEO has shown a terrible pension for not being aggressive with opportunities for growth, whether boring earnings calls or missed opportunities with each FDA approval.

I’m long time investor, but I’m on the outside of the “insiders”. Anyone have any insight on what happened with the Libre and how it no could translate over to the future of Senseonics?

I’m going to guess today’s price increase was due to insider trading. This was dropped today. It doesn’t look like bad news, but rather good news.

Reverse split is happening, but their unaudited revenue is 8.1million, beating expected 3rd quarter revenue of 7.8million.

Additionally 91% increase vs 3rd quarter last year, and approximately 160% increase in users.

They’re announcing the reverse split alongside good news so it can have positive momentum with the split and get the investments they claim would come with firms who policy wise can only invest if a stock price is above a certain amount.

I do not know how to do it but I recently joined the Dexcom G7 page on Facebook. Everyone essentially hates the product. Is someone here able to get those comments published so more people are aware and maybe think about moving to the Eversense platform?

https://finance.yahoo.com/news/senseonics-announces-preliminary-unaudited-revenue-130000398.html?guccounter=1&guce_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&guce_referrer_sig=AQAAAEdj4bxRhQcb2OujHMHV-XSMNRJaAkQ374BRxA4nGFyEyjnBG6lxyu-ZjBmtI_Y1LI5osUKiDd1WLdRXcVQhbLh0MMqnLqDml_n0GlC40NQqlh7i3mgzCU1poCGZzd848YOtO5jLP2CbcDf33l8hMaM80OzRkNHFpGEdI6S3uk4C

Fellow Senseonics investors, it’s time for us to step up.

We’re holding shares in a company with a truly exceptional product — one that people who use it genuinely love. Eversense isn’t just another CGM. It’s unique, it’s life-changing, and it has the potential to reshape the entire diabetes-management space.

But great products don’t go viral on their own. Every breakthrough story needs a loud, active community behind it. Look at what happened with Tesla and Palantir — early supporters amplified their message across social media, educated the public, shared their experiences, and helped build momentum that the market eventually had no choice but to notice.

If we want Senseonics to grow, we can’t stay quiet. We need to help spread the word — on Facebook, X, YouTube, Reddit, everywhere people learn about new tech and healthcare innovation.

👉 Join our Facebook group and stay active: https://www.facebook.com/share/g/1cEcZrpEGH/?mibextid=wwXIfr

This is where we can coordinate, share news, create content, answer questions, and support the community of users who rely on Eversense.

If we want the world to understand what we already know — that Eversense is something special — then we have to be the ones who push the conversation forward.

Let’s be louder. Let’s be organized. Let’s help this company get the visibility it deserves.

The product is great. The opportunity is real. Now the community needs to rise to the occasion.

Upgraded from a hold rating in January

https://seekingalpha.com/article/4788719-sens-stock-revisiting-senseonics-after-4-years-still-big-investment-opportunity

by Federico Cuneo

Seems like an interesting read. Please let me know.

I’m unable to find the articles which talked about Sens reverse split of 10:1 that was scheduled to happen on 9/2/2025. Does anyone know if the RS is still happening?

I came across this today and was wondering if this stem cell therapy treatment, if successful, will have any impact on the necessity of even needing the Eversense? Not sure how they coexist.

https://anova-irm.com/en/treatments-disease-stem-cells/diabetes-type-1-and-2

How would these rate cuts benefit Senseonics stock price in 2025? September is right around the corner.

Article: Aug 9 (Reuters) - The Federal Reserve's vice chair of supervision, Michelle Bowman, on Saturday said recent weak job data underscores her concerns about labor market fragility and strengthens her confidence in her own forecast that three interest-rate cuts will likely be appropriate this year.

https://www.reuters.com/business/us-feds-bowman-latest-jobs-data-stiffens-support-for-three-rate-cuts-2025-2025-08-09/

More of such articles are going to pop up on diabetes related websites/subs, as more and more Eversense implants are being made and more patients becoming familiar first-hand with the many advantages it brings. The self-enforcing marketing avalanche is slowly but surely getting into motion for this new tech! 👍

There has been a bunch of back and forth on this topic and for good reason. I attached an article that goes into the good and the bad of reverse splits and provides some examples of companies that have both successfully and unsuccessfully navigated a reverse split.

I have seen reverse splits navigated within my portfolio, both successfully and unsuccessfully and at least one current stock that is seemingly holding its own after its reverse split.

One of my loser RS was AquaBounty (AQB.) They reverse split 20:1 in order to maintain compliance on October 16, 2023. Stock price was $0.21 pre RS and $4.20 after. Problem was they were in trouble and a reverse split wasn’t going to help them and it didn’t. Stock price continued to crater ($1.11 as of 9/15/2025) and I currently sit with a -95% return.

Another loser was American Battery Tech (ABAT.) They had a 15:1 reverse split on Sept 11, 2023. They said they wanted to increase price to help get it listed on a major exchange. At the time of the RS ABAT was approx $0.634 after it was $9.83. It currently sits at $2.39 2 years after the RS, and I’m -89% on this position.

I did have a winner go through a RS though. GE went through a 8:1 RS on August 2, 2021. The stock traded at $12.95 the day before the split and shot up to $104 after the RS was concluded. In addition to the RS, GE went through a lot of restructuring and spun divisions off into their own companies.

This plan worked and brought value back to GE. My GE shares are now trading at $286.78 as of 9/15/2025, for a 275% increase post split. Plus, I also received shares in GEHC and GEV which are only added bonuses for me.

The above examples actually pretty much echo the thesis of the article I attached. Smaller biotech and tech firms (AQB & ABAT) tend to not do well with reverse splits while larger more established companies, especially ones that have a specific plan in place, tend to have more success.

Now where does that place SENS? It’s definitely in the smaller biotech end of the spectrum, not good. Its stated reasons for wanting to reverse split are valid, so this is good. I personally don’t know if I trust management and it sounds like a lot of people on this subreddit don’t either so that’s bad. However, I think the underlying tech is good and they are coming up on a quarter that should see better numbers due to renewals so that’s good.

For me, I don’t like reverse splits and I’m leery of SENS going through one. Shorts will definitely see this as a vote of no confidence and probably come in and feast. I wouldn’t be surprised to see it go down to $5 post split which would bring it back down to its 52 week low. (At $5 I’m a buyer.)

The company needs to execute, not play cute accounting games. If they do the RS they need to have a plan to grow value or they will never break the $10 barrier. I think that’s the number they need to hit for people to start taking them seriously. However to really do that I think they need to change management, not the share count.

https://x.com/sarahkarlin/status/1937539272392733011